omega-n-methylarginine has been researched along with cardiovascular agents in 9 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (cardiovascular agents) | Trials (cardiovascular agents) | Recent Studies (post-2010) (cardiovascular agents) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 17,645 | 1,480 | 6,891 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choate, JK; Paterson, DJ; Sears, CE | 1 |
| Jan, CR; Lo, WC; Tseng, CJ; Wu, SN | 1 |
| Dankelman, J; Goto, M; Kajiya, F; Merkus, D; Spaan, JA; Vergroesen, I; Vink, H | 1 |
| Ashworth, JR; Baker, PN; Johnson, IR; Warren, AY | 1 |
| Amoroso, G; Baglini, R; Limbruno, U; Mariani, M; Mariotti, R; Merelli, A; Paterni, G; Petronio, AS | 1 |
| Buralli, S; Gennazzani, A; Ghiadoni, L; Lombardo, M; Petraglia, F; Pinto, S; Salvetti, A; Taddei, S; Virdis, A | 1 |
| Davies, MG; Hagen, PO; Huynh, TT | 1 |
| Broadley, AJ; Cockcroft, JR; Frenneaux, MP; Gunaruwan, P; Lee, L; Nightingale, AK; Payne, N; Schmitt, M; Struthers, AD; Taylor, J; Tyberg, JV | 1 |
| Caplin, B; Leiper, J | 1 |
1 review(s) available for omega-n-methylarginine and cardiovascular agents
| Article | Year |
|---|---|
Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?
Topics: Amidohydrolases; Animals; Arginine; Binding Sites; Binding, Competitive; Biomarkers; Cardiovascular Agents; Cardiovascular Diseases; Catalytic Domain; Enzyme Inhibitors; Humans; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine | 2012 |
8 other study(ies) available for omega-n-methylarginine and cardiovascular agents
| Article | Year |
|---|---|
Inhibition of nitric oxide synthase slows heart rate recovery from cholinergic activation.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Animals; Arginine; Calcium Channel Blockers; Cardiovascular Agents; Cesium; Electric Stimulation; Enzyme Inhibitors; Guinea Pigs; Heart Atria; Heart Rate; Male; Nifedipine; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Pyrimidines; Vagus Nerve | 1998 |
Cardiovascular effects of nitric oxide and adenosine in the nucleus tractus solitarii of rats.
Topics: Adenosine; Animals; Arginine; Blood Pressure; Cardiovascular Agents; Enzyme Inhibitors; Heart Rate; Male; Microinjections; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Sodium Chloride; Solitary Nucleus; Xanthines | 1998 |
Prolonged diastolic time fraction protects myocardial perfusion when coronary blood flow is reduced.
Topics: Adenosine; Animals; Blood Pressure; Cardiac Pacing, Artificial; Cardiovascular Agents; Coronary Circulation; Diastole; Dogs; Enzyme Inhibitors; Heart; Muscle Relaxation; Myocardial Ischemia; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Perfusion; Time Factors; Vascular Resistance | 1999 |
Mechanisms of endothelium-dependent relaxation in myometrial resistance vessels and their alteration in preeclampsia.
Topics: Adult; Bradykinin; Cardiovascular Agents; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Indomethacin; Myometrium; omega-N-Methylarginine; Pre-Eclampsia; Pregnancy; Vascular Resistance; Vasodilation | 1999 |
The impact of coronary artery disease on the coronary vasomotor response to nonionic contrast media.
Topics: Aged; Cardiovascular Agents; Contrast Media; Coronary Angiography; Coronary Circulation; Coronary Disease; Coronary Vessels; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Indomethacin; Male; Middle Aged; omega-N-Methylarginine; Oxygen; Time Factors; Triiodobenzoic Acids; Vasomotor System | 2000 |
Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women.
Topics: Acetylcholine; Adult; Arginine; Ascorbic Acid; Blood Pressure; Cardiovascular Agents; Endothelium, Vascular; Enzyme Inhibitors; Estrogen Replacement Therapy; Estrogens; Female; Forearm; Humans; Indomethacin; Leiomyoma; Middle Aged; omega-N-Methylarginine; Ovariectomy; Postoperative Period; Reference Values; Regional Blood Flow; Uterine Neoplasms; Vasodilation; Vasodilator Agents | 2000 |
Characterization of dopamine-mediated relaxation in experimental vein bypass grafts.
Topics: Adjuvants, Immunologic; Adrenergic alpha-Antagonists; Animals; Cardiotonic Agents; Cardiovascular Agents; Carotid Artery, Common; Cholera Toxin; Dopamine; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Graft Occlusion, Vascular; GTP-Binding Proteins; Hyperplasia; Indomethacin; Jugular Veins; Male; Nitric Oxide; omega-N-Methylarginine; Phenoxybenzamine; Prostaglandins; Rabbits; Receptors, Adrenergic, alpha; Receptors, Dopamine; Tunica Intima; Vasodilation | 2000 |
Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Arteries; Atrial Natriuretic Factor; Cardiovascular Agents; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Heart Failure; Humans; Injections, Intra-Arterial; Male; Middle Aged; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Natriuretic Peptides; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Peptide Fragments; Tetrahydroisoquinolines; Vascular Resistance; Vasodilation; Veins | 2004 |